Mark A. Velleca - PRESIDENT & CEO, Director at Black Diamond Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
PRESIDENT & CEO, Director
Stock Symbol
BDTX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Mark A. Velleca since 10/5/2023

Holdings reported by Mark A. Velleca for Black Diamond Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 46.5K $127K $2.73 Sep 15, 2023 Direct
Stock Option (Right to Buy) 537K Feb 14, 2024 Direct Common Stock

Transactions reported by Mark A. Velleca for Black Diamond Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.